A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy. (Q54374407)
Jump to navigation
Jump to search
scientific article published on 27 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy. |
scientific article published on 27 February 2014 |
Statements
A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy. (English)
Toni K Choueiri
Jorge A Garcia
Gary R Hudes
Walter M Stadler
Laura S Wood
Jayne Gurtler
Shailender Bhatia
Adarsh Joshi
Rebecca R Hozak
Yihuan Xu
Jonathan D Schwartz
John A Thompson
27 February 2014
120
11
1647-1655
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference